Hasil Pencarian - Jack Roth

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Reproducibility of SELDI Spectra across Time and Laboratories

    Reproducibility of SELDI Spectra across Time and Laboratories oleh Lixia Diao, Charlotte H. Clarke, Kevin R. Coombes, Stanley R. Hamilton, Jack Roth, Li Mao, Bogdan Czerniak, Keith A. Baggerly, Jeffrey S. Morris, Eric T. Fung, Robert C. Bast

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Reproducibility of SELDI Spectra Across Time and Laboratories

    Reproducibility of SELDI Spectra Across Time and Laboratories oleh Lixia Diao, Charlotte H. Clarke, Kevin R. Coombes, Stanley R. Hamilton, Jack Roth, Li Mao, Bogdan Czerniak, Keith A. Baggerly, Jeffrey S. Morris, Eric T. Fung, Robert C. Bast Jr

    Diterbitkan 2011-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    174 Combined IL-2, agonistic CD3 and 4–1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes

    174 Combined IL-2, agonistic CD3 and 4–1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes oleh Alexandre Reuben, Cara Haymaker, Chantale Bernatchez, John Heymach, Tina Cascone, Jianjun Zhang, Ara Vaporciyan, Boris Sepesi, Ignacio Wistuba, Lorenzo Federico, Junya Fujimoto, Parin Shah, Jack Roth, Don Gibbons, Marie Andree Forget, Marcelo Negrao, Meredith Frank, Peixin Jiang, Roohussaba Khairullah, Chi-Wan Chow, Yan Long, Shiaw-Yih Lin, Kyle Mitchell, Annika Weissferdt, Daniel McGrail

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    277 Combined neoadjuvant chemo-immunotherapy therapy achieves superior downstaging of resectable non-small cell lung cancer as compared to chemotherapy, mono or dual immunotherapy

    277 Combined neoadjuvant chemo-immunotherapy therapy achieves superior downstaging of resectable non-small cell lung cancer as compared to chemotherapy, mono or dual immunotherapy... oleh Heather Lin, Charles Lu, Mehmet Altan, Apar Pataer, Tina Cascone, Annikka Weissferdt, Jianjun Zhang, Ara Vaporciyan, Boris Sepesi, Ferdinandos Skoulidis, Erin Corsini, Mara Antonoff, George Blumenschein, Yasir Elamin, Frank Fossella, Bonnie Glisson, Wayne Hofstetter, Jonathan Kurie, Xiuning Le, Cheuk Hong Leung, Reza Mehran, Frank Mott, David Rice, Jack Roth, Stephen Swisher, Anne Tsao, Garret Walsh, Don Gibbons

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers

    MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers oleh Omar Alhalabi, Jianfeng Chen, Yuxue Zhang, Yang Lu, Qi Wang, Sumankalai Ramachandran, Rebecca Slack Tidwell, Guangchun Han, Xinmiao Yan, Jieru Meng, Ruiping Wang, Anh G. Hoang, Wei-Lien Wang, Jian Song, Lidia Lopez, Alex Andreev-Drakhlin, Arlene Siefker-Radtke, Xinqiao Zhang, William F. Benedict, Amishi Y. Shah, Jennifer Wang, Pavlos Msaouel, Miao Zhang, Charles C. Guo, Bogdan Czerniak, Carmen Behrens, Luisa Soto, Vassiliki Papadimitrakopoulou, Jeff Lewis, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Jack Lee, Jack Roth, Stephen Swisher, Ignacio Wistuba, John Heymach, Jing Wang, Matthew T. Campbell, Eleni Efstathiou, Mark Titus, Christopher J. Logothetis, Thai H. Ho, Jianjun Zhang, Linghua Wang, Jianjun Gao

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: